Catalyst Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Catalyst Pharmaceuticals

10/05/2023 22:01

* Catalyst Pharmaceuticals Inc  CPRX.OQ  reported quarterly
adjusted earnings of 26 cents​​ per share for the quarter ended
in March. The mean expectation of five analysts for the quarter
was for earnings of 32 cents per share.
    * Revenue rose 98.1% to $85.37 million from a year ago;
analysts
expected $81.62 million. 
    * Catalyst Pharmaceuticals Inc's reported EPS for the
quarter was
26 cents​.
    * The mean earnings estimate of analysts had risen by
about 20.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Catalyst Pharmaceuticals Inc shares had risen by 4.9% this
quarter and lost 6.5% so far this year.
    * The company reported quarterly net income of $29.57
million.
    * Wall Street's median 12-month price target for Catalyst
Pharmaceuticals Inc is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.32           0.26           Missed
 Dec. 31 2022      0.21           0.22           Beat
 Sep. 30 2022      0.19           0.20           Beat
 Jun. 30 2022      0.17           0.20           Beat